Willis Towers Watson (WTW) reported fourth‑quarter 2025 revenue of $2.94 billion, a 3% decline from the prior year but a 6% organic increase when adjusted for currency and portfolio changes. Net income fell to $736 million from $1.25 billion a year earlier, while adjusted EBITDA reached $1.12 billion, or 38.2% of revenue, slightly down from 38.9% a year ago. The company’s free‑cash‑flow climbed to $1.55 billion from $1.27 billion a year earlier. Earnings per share of $8.12 beat the consensus estimate of $7.92, a $0.20 or 2.5% beat.
The revenue decline was largely a result of the sale of the TRANZACT business, which removed a $200 million‑plus revenue stream from the top line. Despite that, organic growth in the core Health, Wealth & Career (HWC) and Risk & Broking (R&B) segments drove the 6% and 7% organic revenue gains, respectively, offsetting the divestiture headwind and supporting the company’s long‑term growth strategy.
Adjusted EBITDA margin contracted from 38.9% to 38.2% YoY, but operating margin expanded by 80 basis points to 25.2% in Q4. The margin shift reflects a mix of higher‑margin work in HWC and R&B, disciplined cost control, and the impact of one‑time impairment charges related to the TRANZACT sale. The company’s portfolio optimization program has reduced lower‑margin legacy exposure, allowing the remaining businesses to operate more efficiently.
Net income fell YoY because of higher operating expenses and a one‑time impairment related to the divestiture, yet the company still delivered an EPS beat. The EPS beat was driven by strong pricing power in the core segments, effective cost management, and a favorable share‑count base. The company’s guidance for 2025 remains unchanged, with management confident it will hit its organic growth, margin expansion, and free‑cash‑flow targets.
Full‑year 2025 revenue was $9.71 billion, a 2% decline from $9.93 billion, but net income of $1.61 billion reversed a $88 million loss in 2024. Free‑cash‑flow rose to $1.55 billion, reflecting the cash generated from the TRANZACT sale and ongoing cost discipline. The company’s 5% organic revenue growth and margin expansion underpin its positive outlook for 2026, where it expects mid‑single‑digit organic growth and continued margin improvement.
Management highlighted that the results were driven by strong performance in HWC and R&B, and that the company remains on track to meet its 2025 guidance. CEO Carl Hess said, “We delivered margin expansion along with our growth,” and added, “We see AI as an opportunity for the organization.” President of Risk & Broking Lucy Clarke emphasized the importance of talent, noting, “Our business is really all about the people.”
Market reaction was positive, with WTW shares rising 3.47% in pre‑market trading and 5.6% in morning trading. The gains were driven by the EPS and revenue beats, the margin expansion, and the company’s confidence in its 2025 guidance and 2026 growth outlook.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.